Literature DB >> 19271942

Bladder dysfunction in multiple sclerosis.

Pamela A McCombe1, Thomas P Gordon, Michael W Jackson.   

Abstract

Multiple sclerosis (MS) is a relatively common disease of young adults. Patients with MS can have a wide range of symptoms and may develop significant disability. The cause of MS is unknown, but immunological mechanisms are important. In MS, the pathological features include prominent demyelination and inflammation, but there is also evidence of neurodegeneration. Bladder symptoms are common in MS. The bladder is under neural control, and bladder disturbance is usually attributed to demyelination or loss of axons from the neural pathways, particularly those in the spinal cord, that control the bladder. However, as with other symptoms in MS, the presence of bladder disturbance does not always correlate well with MRI lesions. We speculate that other possible causes of bladder dysfunction in MS might include the effects of circulating toxic factors. Urgency of micturition is prominent in MS, and better understanding of the receptors involved in bladder sensation suggests possible treatment strategies through inhibiting these receptors.

Entities:  

Mesh:

Year:  2009        PMID: 19271942     DOI: 10.1586/14737175.9.3.331

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

1.  Lower urinary tract symptom prevalence and management among patients with multiple sclerosis.

Authors:  Kristin M Khalaf; Karin S Coyne; Denise R Globe; Edward P Armstrong; Daniel C Malone; Jack Burks
Journal:  Int J MS Care       Date:  2015 Jan-Feb

2.  Coronavirus-induced demyelination of neural pathways triggers neurogenic bladder overactivity in a mouse model of multiple sclerosis.

Authors:  Matthew T McMillan; Xiao-Qing Pan; Ariana L Smith; Diane K Newman; Susan R Weiss; Michael R Ruggieri; Anna P Malykhina
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09

Review 3.  Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research.

Authors:  Ramalakshmi Ramasamy; Phillip P Smith
Journal:  Neurourol Urodyn       Date:  2021-03-14       Impact factor: 2.696

4.  Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model.

Authors:  Hiromitsu Negoro; Sarah E Lutz; Louis S Liou; Akihiro Kanematsu; Osamu Ogawa; Eliana Scemes; Sylvia O Suadicani
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 5.  New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction.

Authors:  Minoru Miyazato; Katsumi Kadekawa; Takeya Kitta; Naoki Wada; Nobutaka Shimizu; William C de Groat; Lori A Birder; Anthony J Kanai; Seiichi Saito; Naoki Yoshimura
Journal:  Urol Clin North Am       Date:  2017-08       Impact factor: 2.241

6.  Effects of behavioural therapy versus interferential current on bladder dysfunction in multiple sclerosis patients; a randomised clinical study.

Authors:  Abdullah M Al-Shenqiti; Walaa M Ragab; Esraa H Rostum; Hatem A Emara; Osama A Khaled
Journal:  J Taibah Univ Med Sci       Date:  2021-09-01

7.  Grey and White Matter Magnetisation Transfer Ratio Measurements in the Lumbosacral Enlargement: A Pilot In Vivo Study at 3T.

Authors:  Chinyere O Ugorji; Rebecca S Samson; Martina D Liechti; Jalesh N Panicker; David H Miller; Claudia A M Wheeler-Kingshott; Marios C Yiannakas
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

8.  The use of the lumbosacral enlargement as an intrinsic imaging biomarker: feasibility of grey matter and white matter cross-sectional area measurements using MRI at 3T.

Authors:  Marios C Yiannakas; Puneet Kakar; Luke R Hoy; David H Miller; Claudia A M Wheeler-Kingshott
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

9.  Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T.

Authors:  Marios C Yiannakas; Francesco Grussu; Polymnia Louka; Ferran Prados; Rebecca S Samson; Marco Battiston; Daniel R Altmann; Sebastien Ourselin; David H Miller; Claudia A M Gandini Wheeler-Kingshott
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

10.  Management strategies for lower urinary tract symptoms (LUTS) among people with multiple sclerosis (MS): a qualitative study of the perspectives of people with MS and healthcare professionals.

Authors:  Hawra B Al Dandan; Rose Galvin; Doreen McClurg; Susan Coote
Journal:  HRB Open Res       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.